Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122926 · ClinicalTrials.gov registry record · NA
Intensive Discharge Intervention in Diabetes
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT02122926 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 180 participants.
The verdict
NCT02122926, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The goal of this study is to design and implement an intensive discharge intervention for inpatients with type 2 diabetes and cardiovascular disease, and determine the effects of the intervention on post-discharge insulin adherence, glycemic control, cardiac medication adherence, hypoglycemic events, and emergency department visits and hospital readmissions.
Interventions
- OTHER Intensive discharge intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02122926
The ClinicalTrials.gov registry entry for NCT02122926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intensive discharge intervention is the first listed.
NCT02122926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02122926 about?
NCT02122926 is a clinical study titled "Intensive Discharge Intervention in Diabetes". The goal of this study is to design and implement an intensive discharge intervention for inpatients with type 2 diabetes and cardiovascular disease, and determine the effects of the intervention on post-discharge insulin adherence, glycemic control, cardiac medication adherence, hypoglycemic events...
What is the current status of trial NCT02122926?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2011-12. Estimated completion is 2013-07.
What interventions are being tested in trial NCT02122926?
The interventions under investigation include: Intensive discharge intervention (OTHER).
Who is sponsoring clinical trial NCT02122926?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.